Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8632357 | Journal of Diabetes and its Complications | 2018 | 4 Pages |
Abstract
In patients with T1D and IAH, treated with standard SMBG, a negative association exists between HbA1c and the number of severe hypoglycemic events. Thus, reaching target HbA1c values still comes with a higher risk of severe hypoglycemia. CGM weakens this association, suggesting CGM enables patients to reach their target HbA1c more safely.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Cornelis A.J. van Beers, Martine G. Caris, J. Hans DeVries, Erik H. Serné,